ÂÜÀòÂÒÂ×

With over 23 years specializing in payer strategy and execution for a top biopharma manufacturer, Amy has worked with brand marketing and pipeline teams to develop and execute market access strategies and payer value propositions for over 50 unique brands.

Amy was an early market access expert on key biopharma pipeline trends to include specialty pharmacy, oncology, rare disease, gene therapy, and biosimilars. Amy’s areas of expertise include rebate strategies, competitive landscape mapping, early pipeline market assessments, and strengthening forecasts with payer research inputs.